EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer’s disease mutations

Iason Keramidis iD, Brendan B McAllister, Julien Bourbonnais, Feng Wang iD, Dominique Isabel, Edris Rezaei, Romain Sansonetti, Phil Degagne, Justin P Hamel, Mojtaba Nazari, Samsoon Inayat, Jordan C Dudley und 6 weitere

Brain · 01.12.2023 · 146 (12) · 4903-4915

DOI: 10.1093/brain/awad250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 08.08.2023. Verfasst von Iason Keramidis und 17 weiteren Autor:innen. Beteiligte Einrichtung: CERVO Brain Research Centre, Quebec Mental Health Institute, Québec, QC G1E 1T2, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Symporters. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Weston Brain Institute Transformation Research, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disinhibition during early stages of Alzheimer's disease is postulated to cause network dysfunction and hyperexcitability leading to cognitive deficits. However, the underlying molecular mechanism remains unknown. Here we show that, in mouse lines carrying Alzheimer's disease-related mutations, a loss of neuronal membrane potassium-chloride cotransporter KCC2, responsible for maintaining the robustness of GABAA-mediated inhibition, occurs pre-symptomatically in the hippocampus and prefrontal cortex. KCC2 downregulation was inversely correlated with the age-dependent increase in amyloid-β 42 (Aβ42). Acute administration of Aβ42 caused a downregulation of membrane KCC2. Loss of KCC2 resulted in impaired chloride homeostasis. Preventing the decrease in KCC2 using long term treatment with CLP290 protected against deterioration of learning and cortical hyperactivity. In addition, restoring KCC2, using short term CLP290 treatment, following the transporter reduction effectively reversed spatial memory deficits and social dysfunction, linking chloride dysregulation with Alzheimer's disease-related cognitive decline. These results reveal KCC2 hypofunction as a viable target for treatment of Alzheimer's disease-related cognitive decline; they confirm target engagement, where the therapeutic intervention takes place, and its effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionSymportersMiceAnimalsChloridesAmyloid beta-PeptidesMutationDisease Models, Animal

Stichwörter der Autor:innen

App NL-G-F/NL-G-F5xFADAlzheimer’s diseaseKCC2chloride homeostasisinhibition

Substanzen

ChloridesAmyloid beta-PeptidesSymporters

Autor:innen und Institutionen

  • CERVO Brain Research Centre, Quebec Mental Health Institute, Québec, QC G1E 1T2, Canada.
  • Graduate Program in Neuroscience, Faculty of Medicine, Université Laval, Québec, QC G1V 0A6, Canada.
  • Canadian Centre for Behavioural Neuroscience, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.
  • Faculty of Dentistry, Université Laval, Québec, QC G1V 0A6, Canada.
  • Department of Biochemistry, Microbiology, and Bio-informatics, Université Laval, Québec, QC G1V 0A6, Canada.
  • Department of Psychiatry and Neuroscience, Université Laval, Québec, QC G1V 0A6, Canada.

ORCID-Profile: Iason Keramidis, Feng Wang, Antoine G Godin, Yves De Koninck

Förderung

  • CIHR
  • Weston Brain Institute Transformation Research
  • Canadian Institutes of Health Research
  • Canada Research Chair
  • Fonds de recherche du Québec—Santé
  • Canada First Research Excellence Fund
  • Natural Sciences and Engineering Research Council of Canada
  • Norampac Research

Zitieren

APA

Keramidis, I., McAllister, B. B., Bourbonnais, J., Wang, F., Isabel, D., Rezaei, E., Sansonetti, R., Degagne, P., Hamel, J. P., Nazari, M., Inayat, S., Dudley, J. C., Barbeau, A., Froux, L., Paquet, M. E., Godin, A. G., Mohajerani, M. H., & De Koninck, Y. (2023). Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer’s disease mutations. Brain, 146(12), 4903-4915. https://doi.org/10.1093/brain/awad250

Vancouver

Keramidis I, McAllister BB, Bourbonnais J, Wang F, Isabel D, Rezaei E, et al. Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer’s disease mutations. Brain. 2023;146(12):4903-4915. doi:10.1093/brain/awad250

BibTeX
@article{Keramidis2023,
  author = {Keramidis, Iason and McAllister, Brendan B and Bourbonnais, Julien and Wang, Feng and Isabel, Dominique and Rezaei, Edris and Sansonetti, Romain and Degagne, Phil and Hamel, Justin P and Nazari, Mojtaba and Inayat, Samsoon and Dudley, Jordan C and Barbeau, Annie and Froux, Lionel and Paquet, Marie-Eve and Godin, Antoine G and Mohajerani, Majid H and De Koninck, Yves},
  title = {Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer’s disease mutations},
  journal = {Brain},
  year = {2023},
  volume = {146},
  number = {12},
  pages = {4903--4915},
  doi = {10.1093/brain/awad250}
}
Kostenlos starten →